Regional geometric differences between regurgitant and non-regurgitant mitral valves in patients with coronary artery

Aidan Sharkey1, Feroze Mahmood1, Ting Hai2

  • 1Department of Anesthesia Critical Care and Pain Management, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Insights

Regional differences in mitral valve (MV) geometry exist in patients with coronary artery disease (CAD). Even without mitral regurgitation (MR), MV reserve varies, indicating potential for future issues.

Area of Science:

  • Cardiovascular Imaging
  • Cardiac Surgery
  • Echocardiography

Background:

  • Coronary artery disease (CAD) can cause heterogeneous ischemic remodeling.
  • This remodeling affects mitral valve (MV) geometry and function.
  • Understanding these changes is crucial for assessing mitral regurgitation (MR) risk.

Purpose of the Study:

  • To investigate regional geometric differences between regurgitant and non-regurgitant MVs in CAD patients.
  • To assess the anatomical reserve and likelihood of developing MR in non-regurgitant MVs within CAD patients.

Main Methods:

  • Retrospective analysis of intraoperative 3D transesophageal echocardiographic data.
  • Comparison of regional MV geometry and MV reserve between patients with (IMR) and without (NMR) MR.
  • Calculation of MV reserve in three distinct MV zones.

Main Results:

  • Significant regional geometric differences were observed between IMR and NMR groups.
  • NMR group had greater coaptation length and MV reserve in zones 1 and 2 compared to the IMR group.
  • Depletion of MV reserve correlated with posterior displacement of the coaptation point.

Conclusions:

  • Significant regional geometric disparities exist between regurgitant and non-regurgitant MVs in CAD.
  • Absence of MR does not equate to normal MV function due to regional variations in anatomical reserve.
  • Assessing MV reserve is vital for predicting MR risk in CAD patients.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
23
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
29
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
27
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
37
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
22
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
22